ArticleBrain circulation
Management of radiological cerebral vasospasm after coil embolization for ruptured intracranial aneurysms: A noninferiority bicentric cohort study.
Article in Brain circulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWhether radiological cerebral vasospasm (CVS) should be proactively treated following subarachnoid hemorrhage to reduce the development of delayed cerebral ischemia (DCI) and brain infarction remains unclear. In this bicentric retrospective study, we sought to determine if a first-line intravenous therapy (IVT) to early detect and treat CVS could be noninferior on neurological outcomes to a first-line endovascular therapy (ET) requiring intra-arterial procedures for confirmed CVS as the reference approach.
methodsTwo cohorts of unselected patients exposed to the risk of CVS were studied following coil embolization for ruptured intracranial aneurysms. In the IVT group, CVS was actively detected and treated using a continuous intravenous infusion of milrinone for at least 7 days. In the ET group, selective intra-arterial infusions of nimodipine and milrinone were performed to treat confirmed CVS, and repeated if necessary. The primary endpoint was the proportion of patients with a good functional neurological outcome at 12 months using the modified Rankin Scale 0-2, with a noninferiority margin of 15%.
resultsThe good outcome of patients exposed to the risk of CVS was noninferior between the IVT and ET strategies: 108/119 patients (91%; 95% confidence interval [CI] 84% to 95%) versus 77/97 patients (79%; 95% CI: 70% to 87%), respectively. The IVT strategy led to the diagnosis of CVS in more patients in a shorter delay, and a reduced proportion of patients with DCI and brain infarction. There was no difference in the drug-related side effects between the two groups.
conclusionA proactive intravenous treatment with milrinone to treat CVS had noninferior functional outcome compared to endovascular treatment using the selective intra-arterial infusion of vasodilator drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.